Barend Mitton

Barend Mitton

Auto-generated profile, based on publicly available information

Barend Mitton

Department of Medical Microbiology, Faculty of Health Sciences, University of the Free State, Bloemfontein, South Africa; Universitas Academic Laboratory Complex, National Health Laboratory Service, Pretoria, South Africa

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications

30 November 2021 in Access Microbiology
Verified
Journal Article
Open access
VTVhudzani Tshisevhe
Vhudzani Tshisevhe
BMBarend Mitton
Barend Mitton
LSLebogang Skosana
Lebogang Skosana
Geotrichosis is a world-wide mycosis caused byGeotrichumspecies. We report a rare case of an invasive cutaneous infection byGeotrichum klebahniiin a female patient with undiagnosed diabetes mellitus. The patient presented with right facial swelling not responding to antibiotics and could not recall trauma to the site of the lesion. Histological examination showed fungal hyphae invading salivary glands and bony tissues, andG. klebahniiwas isolated from the culture of biopsy material. Matrix-assisted laser desorption/ionization-time of flight (MALDI-TOF) mass spectrometry (MS) confirmed the fungal species. Broth microdilution showed low minimum inhibitory concentrations (MICs) for itraconazole, posaconazole, voriconazole and amphotericin B. Treatment with sequential administration of intravenous amphotericin B with voriconazole followed by itraconazole led to the resolution of the lesion.

1 October 2019 in Journal of Clinical Microbiology
Verified
Journal Article
Closed access
PDF file
BMB. Mitton
B. Mitton
CKC. Kingsburgh
C. Kingsburgh
MKM. M. Kock
M. M. Kock
NMN. M. Mbelle
N. M. Mbelle
KSK. Strydom
K. Strydom
Colistin has become increasingly important in the treatment of multidrug-resistant Gram-negative bacteria. Resistance to colistin has emerged globally, necessitating the need for an accurate method to detect colistin resistance. The colistin NP test has shown promise as a rapid screening assay for colistin resistance. This study compared the performance of an in-house-prepared colistin NP test against broth microdilution (BMD) as the gold standard and against Etest (bioMérieux, Marcy l’Etoile, France) as an alternative method. A total of 215 stored Enterobacteriaceae isolates were evaluated, of which 159 were resistant and 56 susceptible to colistin by BMD. The categorical agreement of the colistin NP test with BMD was found to be 98.1%, compared to 87.9% for the Etest. One major error was detected with both the colistin NP test and the Etest. Three very major errors were detected with the colistin NP test compared to 25 with the Etest. This resulted in a major error rate of 1.8% for both the colistin NP test and the Etest and a very major error rate of 1.9% and 15.7% for the colistin NP test and the Etest, respectively. The colistin NP test compared satisfactorily to the BMD reference method in determining colistin susceptibility. The colistin NP test is a rapid, inexpensive screening method for colistin resistance, especially in resource-limited settings.

28 March 2022 in Infection Control & Hospital Epidemiology
Verified
Journal Article
Closed access
PDF file
MSMohamed Said
Mohamed Said
BMBarend Mitton
Barend Mitton
LSLebogang Busisiwe Skosana
Lebogang Busisiwe Skosana
KKKatlego Kopotsa
Katlego Kopotsa
RNRashmika Naidoo
Rashmika Naidoo
VAVictoria Amutenya
Victoria Amutenya
Objective: In this study, we sought to determine the source of an outbreak of Achromobacter denitrificans infections in patients at a tertiary-care academic hospital.Design: Outbreak report study with intervention. The study period extended from February 2018 to December 2018.Setting: The study was conducted at a tertiary-care academic hospital in Pretoria, South Africa.Patients and participants: All patients who cultured A. denitrificans from any site were included in this study. During the study period, 43 patients met this criterion.Interventions: Once an outbreak was confirmed, the microbiology laboratory compiled a list of affected patients. A common agent, chlorhexidine-and-water solution, was used as a disinfectant–antiseptic for all affected patients. The laboratory proceeded to culture this solution. Environmental and surface swabs were also cultured from the hospital pharmacy area where this solution was prepared. Repetitive-element, sequence-based, polymerase chain reaction (rep-PCR) was performed on the initial clinical isolates to confirm the relatedness of the isolates.Results: In total, 43 isolates of A. denitrificans were cultured from patient specimens during the outbreak. The laboratory cultured A. denitrificans from all bottles of chlorhexidine-and-water solutions sampled from the wards and the pharmacy. The culture of the dispenser device used to prepare this solution also grew A. denitrificans. The rep-PCR confirmed the clonality of the clinical isolates with 2 genotypes dominating.Conclusions: Contaminated chlorhexidine-and-water solutions prepared at the hospital pharmacy was determined to be the source of the outbreak. Once this item was removed from the hospital, the laboratory did not culture any further A. denitrificans isolates from patient specimens.

1 May 2022 in Cardiovascular Pathology
Verified
Journal Article
Closed access
RGRosemary Griessel
Rosemary Griessel
BMBarend Mitton
Barend Mitton
RRRoxanne Rule
Roxanne Rule
MSMohamed Said
Mohamed Said

20 August 2020 in African Journal of Laboratory Medicine
Verified
Journal Article
Open access
PDF file
BMBarend Mitton
Barend Mitton
RRRoxanne Rule
Roxanne Rule
NMNontombi Mbelle
Nontombi Mbelle
WHWesley van Hougenhouck-Tulleken
Wesley van Hougenhouck-Tulleken
MSMohamed Said
Mohamed Said
Introduction: Bacillus species are often considered as contaminants when cultured from clinical samples. Bacillus cereus may be a pathogen in certain circumstances and is known to cause musculoskeletal infections. This report aims to educate clinicians and clinical microbiology laboratories on B. cereus musculoskeletal infections and to heighten awareness that Bacillus species should not always be dismissed as contaminants. Case presentation: We report the case of a patient who presented to a tertiary hospital in Pretoria, South Africa, in November 2018 with B. cereus septic arthritis and underlying systemic lupus erythematosus (SLE). The isolate would otherwise have been dismissed as a contaminant had it not been for the crucial interaction between the laboratory and the treating clinicians. To our knowledge, this is the first case report of septic arthritis caused by B. cereus in an SLE patient where the organism was cultured from the joint specimen. Identification of the organism was performed using matrix-assisted laser desorption/ionisation mass spectrometry. Management and outcome: Definitive treatment was with intravenous vancomycin, continued for four weeks, in addition to arthroscopy and management of the underlying SLE. The patient had a good clinical outcome and regained full mobility. Conclusion: Musculoskeleta I infections, specifically septic arthritis caused by B. cereus, are exceedingly rare infections. immune suppression, trauma, prosthetic implants and invasive procedures are important risk factors for B. cereus musculoskeletal infections. Close collaboration with a multi-disciplinary team approach will effect the best outcome for complicated patients with B. cereus infections.